Sanofi India

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE058A01010
NSEID: SANOFI
BSEID: 500674

INR

4,312.95

-58.75 (-1.34%)

BSENSE

Dec 05

BSE+NSE Vol: 8.84 k

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Acutaas Chemical

Granules India

P & G Health Ltd

Strides Pharma

Alivus Life

Blue Jet Health

Marksans Pharma

Sanofi Consumer

Sanofi India

Rubicon Research

Sudeep Pharma

Why is Sanofi India Ltd ?

Poor long term growth as Net Sales has grown by an annual rate of -8.47% and Operating profit at -5.55% over the last 5 years

Flat results in Sep 25

Below par performance in long term as well as near term

Along with generating -31.46% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sanofi India for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Sanofi India

-31.41%

-1.47

21.43%

Sensex

4.83%

0.41

11.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-8.47%

EBIT Growth (5y)

-5.55%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.37

Sales to Capital Employed (avg)

2.17

Tax Ratio

26.37%

Dividend Payout Ratio

65.08%

Pledged Shares

Institutional Holding

27.86%

ROCE (avg)

116.06%

ROE (avg)

49.40%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

12.90

EV to EBIT

20.33

EV to EBITDA

18.86

EV to Capital Employed

19.97

EV to Sales

5.07

PEG Ratio

Dividend Yield

4.38%

ROCE (Latest)

95.33%

ROE (Latest)

47.39%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

OBV

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

PAT(9M)

Higher at Rs 285.28 Cr

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Sanofi India

Profit After Tax (PAT) - Nine Monthly

At Rs 285.28 cr has Grown at 54.80%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very positive

PAT (Rs Cr)

Profit After Tax (PAT) - Nine Monthly

Higher at Rs 285.28 Cr

than preceding 12 month period ended Sep 2025 of Rs 269.61 cr

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

PAT (Rs Cr)